In March, the F.D.A. approved Wegovy to reduce the risk of heart attack, stroke and cardiovascular-related death in adults who have heart disease and are overweight or have obesity.
The Food and Drug Administration on Monday approved a pill version of the blockbuster weight-loss injectable drug Wegovy, offering patients who fear or are uncomfortable with needles a more palatable option.
Google’s parent company will acquire Intersect for $4.75 billion to “enable more data center and generation capacity to come online, faster, while accelerating energy development and innovation,” according to a press release. Intersect will “remain separate from Alphabet and... See more
“During the aging process, we begin to lose muscle,” typically half a percent to 1 percent of muscle weight per year, said Dr. Zhenqi Liu, an endocrinologist at the University of Virginia who studies the effects of weight loss drugs. “For people on these medications, the process is much more accelerated.”